Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization

Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization

Cancer is still one of the major diseases worldwide. The discovery of new drugs and the improvement of existing ones is one of the areas of priority in the fight against cancer. Dioxadet ([5-[[4,6-bis(aziridin-1-yl)-1,3,5-triazin-2-yl]amino]-2,2-dimethyl-1,3-dioxan-5-yl]methanol) represents one of t...

Full description

Bibliographic Details
Main Authors: Ekaterina Sinitsyna, Irina Bagaeva, Erik Gandalipov, Evgenia Fedotova, Viktor Korzhikov-Vlakh, Tatiana Tennikova, Evgenia Korzhikova-Vlakh
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
1,3,5-triazine derivatives
dioxadet
nanomedicines
anticancer drugs
polymer nanoparticles
nanoprecipitation
Online Access:https://www.mdpi.com/1999-4923/14/11/2506

Similar Items

Similar Items